Stay updated on Nivolumab Combo in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in Head & Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.8.0 instead of v3.7.2. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:45:28.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A notice announces NIH website updates and says some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-26T16:38:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 on the access-denied page.
    Difference
    0.2%
    Check dated 2026-10-19T20:43:54.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The error page’s footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T03:57:59.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details with an error screen and navigation/footer, indicating that the NCT03342911 record is currently inaccessible.
    Difference
    20%
    Check dated 2026-09-21T22:37:25.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.6.6 has been added to the page, replacing the prior revision. This is a minor maintenance update and does not alter the study details, eligibility criteria, or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-08-31T16:53:32.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Head & Neck Cancer Clinical Trial page.